To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

PRP reduces donor site knee pain in bone-patellar tendon-bone ACL reconstruction

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2013

PRP reduces donor site knee pain in bone-patellar tendon-bone ACL reconstruction

Vol: 2| Issue: 4| Number:26| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Autologous platelet-rich plasma gel to reduce donor-site morbidity after patellar tendon graft harvesting for anterior cruciate ligament reconstruction: a randomized, controlled clinical study

Knee Surg Sports Traumatol Arthrosc. 2012 Jan;20(1):114-20. doi: 10.1007/s00167-011-1570-5. Epub 2011 Jun 16

Contributing Authors:
M Cervellin L de Girolamo C Bait M Denti P Volpi

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

40 patients who required bone-patellar tendon-bone ACL reconstruction were randomized to have platelet-rich plasma (PRP) gel applied or no PRP additive to determine its effect on pain and donor-site morbidity following surgery. Visual Analog Scales (VAS), Victorian Institute Sport Assessment scores and MRI analysis were recorded 12 months postoperatively. The results suggested that patients who re...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue